Replies to post #26126 on GeneSYS ID Inc fka GNID

[Snug Harbour]

You left out the big one when valuating a companies share price. It's called revenue.. how much money does this company actually make. I don't care about the future plans and promises any OTC company spews when valuing it's share price, because 95% of it is bullshit.

[Toxic Avenger]

I'm afraid you are completely wrong. You're starting with the erroneous assumption that ANYONE would hand them $40 million (they have so far failed to receive the $1 million "starting equity") with the current balance sheet and share structure.

In fact, in IPOs, there's a commitment from the underwriter to buy all the shares allocated to them at a fixed price. That determines valuation. Then the underwriter must sell those shares to their customers. The fact that WS is not underwriting this offering, but simply offering it to other investors, who of course, will not take it means they can provide whatever price (value) they want. No exchange will accept that valuation until there are shares being traded at that price.